PExA AB (publ) (FA0.F)
- Previous Close
0.0135 - Open
0.0145 - Bid 0.0150 x --
- Ask 0.0230 x --
- Day's Range
0.0145 - 0.0150 - 52 Week Range
0.0076 - 0.0384 - Volume
0 - Avg. Volume
0 - Market Cap (intraday)
1.423M - Beta (5Y Monthly) 1.13
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0200 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
PExA AB (publ) develops and commercializes diagnostic products in various respiratory diseases. It offers its products for asthma, tuberculosis, cystic fibrosis, lung cancer, and chronic obstructive pulmonary diseases. The company's research instrument helps lung researchers in the collection of microscopic particles and biomarkers for diseases in the small airways. It offers PExA 2.0, an instrument for the non-invasive collection of particles in exhaled air. The company also provides accessories, which include substrate surfaces and nozzles, as well as parts and service kits. It provides its products for lung research centers within the health services, academia, and pharmaceutical companies. The company was founded in 2004 and is based in Gothenburg, Sweden.
pexa.seRecent News: FA0.F
View MorePerformance Overview: FA0.F
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: FA0.F
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: FA0.F
View MoreValuation Measures
Market Cap
1.28M
Enterprise Value
768.16k
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
11.92
Price/Book (mrq)
1.04
Enterprise Value/Revenue
11.65
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-51.62%
Return on Equity (ttm)
-94.75%
Revenue (ttm)
719.62k
Net Income Avi to Common (ttm)
-10.16M
Diluted EPS (ttm)
-0.0200
Balance Sheet and Cash Flow
Total Cash (mrq)
5.59M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-5.55M